• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆和血清调理素对人单核细胞内化可生物降解聚(D,L-乳酸)纳米颗粒作用的研究。

An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytes.

作者信息

Leroux J C, De Jaeghere F, Anner B, Doelker E, Gurny R

机构信息

School of Pharmacy, University of Geneva, Switzerland.

出版信息

Life Sci. 1995;57(7):695-703. doi: 10.1016/0024-3205(95)00321-v.

DOI:10.1016/0024-3205(95)00321-v
PMID:7637541
Abstract

We demonstrate here that polyethylene glycol (PEG) 6,000 protects biodegradable poly(D,L-lactic acid) nanoparticles (PLA NP) from extensive uptake by monocytes in plasma. These results are in agreement with those previously obtained with PEG 20,000 which reduced the uptake of PLA NP by human monocytes in phosphate buffered saline and plasma, and prolonged the NP circulation time in vivo. The coating efficiency of PEG 6,000 and 20,000 was substantially decreased in serum. The difference between the uptake of plain and coated NP clearly reappeared for PEG 20,000-coated NP in heat inactivated serum and in IgG-depleted serum. We suggest that typical plasma proteins, heat labile serum proteins (e.g. complement components) and IgG are involved in the opsonization of plain and coated PLA NP. Other proteins previously found to adsorb onto these NP, namely albumin and apolipoprotein E, did not appear to directly influence the uptake process.

摘要

我们在此证明,聚乙二醇(PEG)6000可保护可生物降解的聚(D,L-乳酸)纳米颗粒(PLA NP)不被血浆中的单核细胞大量摄取。这些结果与先前使用聚乙二醇20000所获得的结果一致,聚乙二醇20000可减少人单核细胞在磷酸盐缓冲盐水和血浆中对PLA NP的摄取,并延长纳米颗粒在体内的循环时间。聚乙二醇6000和20000在血清中的包被效率显著降低。在热灭活血清和IgG耗尽的血清中,聚乙二醇20000包被的纳米颗粒在普通纳米颗粒和包被纳米颗粒摄取之间的差异明显再次出现。我们认为,典型的血浆蛋白、热不稳定血清蛋白(如补体成分)和IgG参与了普通和包被的PLA NP的调理作用。先前发现吸附在这些纳米颗粒上的其他蛋白质,即白蛋白和载脂蛋白E,似乎并未直接影响摄取过程。

相似文献

1
An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytes.血浆和血清调理素对人单核细胞内化可生物降解聚(D,L-乳酸)纳米颗粒作用的研究。
Life Sci. 1995;57(7):695-703. doi: 10.1016/0024-3205(95)00321-v.
2
Internalization of poly(D,L-lactic acid) nanoparticles by isolated human leukocytes and analysis of plasma proteins adsorbed onto the particles.
J Biomed Mater Res. 1994 Apr;28(4):471-81. doi: 10.1002/jbm.820280410.
3
Kinetics of blood component adsorption on poly(D,L-lactic acid) nanoparticles: evidence of complement C3 component involvement.血液成分在聚(D,L-乳酸)纳米颗粒上的吸附动力学:补体C3成分参与的证据。
J Biomed Mater Res. 1997 Nov;37(2):229-34. doi: 10.1002/(sici)1097-4636(199711)37:2<229::aid-jbm12>3.0.co;2-9.
4
PEG-coated poly(lactic acid) nanoparticles for the delivery of hexadecafluoro zinc phthalocyanine to EMT-6 mouse mammary tumours.聚乙二醇包被的聚乳酸纳米颗粒用于向EMT-6小鼠乳腺肿瘤递送十六氟酞菁锌
J Pharm Pharmacol. 1995 May;47(5):382-7. doi: 10.1111/j.2042-7158.1995.tb05815.x.
5
Polymeric nanoparticles encapsulating betamethasone phosphate with different release profiles and stealthiness.包封有不同释放特性和隐身性的磷酸倍他米松的聚合物纳米颗粒。
Int J Pharm. 2009 Jun 22;375(1-2):148-54. doi: 10.1016/j.ijpharm.2009.04.001. Epub 2009 Apr 10.
6
Particle characteristics and biodistribution of camptothecin-loaded PLA/(PEG-PPG-PEG) nanoparticles.载喜树碱的聚乳酸/(聚乙二醇-聚丙二醇-聚乙二醇)纳米粒的粒子特性与生物分布
Drug Deliv. 2008 Jan;15(1):3-10. doi: 10.1080/10717540701827154.
7
Photodynamic therapy of tumours with hexadecafluoro zinc phthalocynine formulated in PEG-coated poly(lactic acid) nanoparticles.用聚乙二醇包被的聚乳酸纳米颗粒配制的十六氟酞菁锌对肿瘤进行光动力治疗。
Int J Cancer. 1996 Jun 11;66(6):821-4. doi: 10.1002/(SICI)1097-0215(19960611)66:6<821::AID-IJC19>3.0.CO;2-5.
8
Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.用于多西他赛口服递送的聚丙交酯-维生素E衍生物/蒙脱石纳米颗粒制剂
Biomaterials. 2009 Jul;30(19):3297-306. doi: 10.1016/j.biomaterials.2009.02.045. Epub 2009 Mar 19.
9
Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles: influence on physical stability and in vitro cell uptake.
Pharm Res. 1999 Jun;16(6):859-66. doi: 10.1023/a:1018826103261.
10
Enhanced gene transfection efficiency in CD13-positive vascular endothelial cells with targeted poly(lactic acid)-poly(ethylene glycol) nanoparticles through caveolae-mediated endocytosis.通过网格蛋白介导的内吞作用,靶向聚乳酸-聚乙二醇纳米粒增强 CD13 阳性血管内皮细胞的基因转染效率。
J Control Release. 2011 Apr 30;151(2):162-75. doi: 10.1016/j.jconrel.2011.02.027. Epub 2011 Mar 3.

引用本文的文献

1
Proteomic characterization of particle-protein coronas shows differences between osteoarthritic and contralateral knees in a rat model.颗粒-蛋白质冠层的蛋白质组学特征显示了大鼠模型中骨关节炎膝关节与对侧膝关节之间的差异。
Connect Tissue Res. 2025 Jan;66(1):59-72. doi: 10.1080/03008207.2025.2459242. Epub 2025 Feb 23.
2
Biodegradable Polymers for Application as Robust Immunomodulatory Biomaterial Carrier Systems.用作强大免疫调节生物材料载体系统的可生物降解聚合物。
Small. 2025 Feb 16:e2409422. doi: 10.1002/smll.202409422.
3
Inflammatory disease progression shapes nanoparticle biomolecular corona-mediated immune activation profiles.
炎症性疾病进展塑造了纳米颗粒生物分子冠介导的免疫激活谱。
Nat Commun. 2025 Jan 22;16(1):924. doi: 10.1038/s41467-025-56210-4.
4
In vivo Biodistribution and Clearance of Magnetic Iron Oxide Nanoparticles for Medical Applications.用于医疗应用的磁性氧化铁纳米粒子的体内生物分布和清除。
Int J Nanomedicine. 2023 Jul 26;18:4067-4100. doi: 10.2147/IJN.S415063. eCollection 2023.
5
Micro and nanotechnologies: The little formulations that could.微米和纳米技术:小制剂的大作为。
Bioeng Transl Med. 2022 Oct 18;8(2):e10421. doi: 10.1002/btm2.10421. eCollection 2023 Mar.
6
Targeted Self-Emulsifying Drug Delivery Systems to Restore Docetaxel Sensitivity in Resistant Tumors.靶向自乳化药物递送系统恢复耐药肿瘤中多西他赛的敏感性
Pharmaceutics. 2022 Jan 26;14(2):292. doi: 10.3390/pharmaceutics14020292.
7
Innate and adaptive immune responses toward nanomedicines.针对纳米药物的先天性和适应性免疫反应。
Acta Pharm Sin B. 2021 Apr;11(4):852-870. doi: 10.1016/j.apsb.2021.02.022. Epub 2021 Mar 13.
8
Opsonins and Dysopsonins of Nanoparticles: Facts, Concepts, and Methodological Guidelines.纳米颗粒的调理蛋白和去调理蛋白:事实、概念和方法学指南。
Front Immunol. 2020 Oct 12;11:567365. doi: 10.3389/fimmu.2020.567365. eCollection 2020.
9
Nanoparticles exhibit greater accumulation in kidney glomeruli during experimental glomerular kidney disease.纳米颗粒在实验性肾小球肾病中在肾小球中表现出更大的蓄积。
Physiol Rep. 2020 Aug;8(15):e14545. doi: 10.14814/phy2.14545.
10
Overcoming Hurdles in Nanoparticle Clinical Translation: The Influence of Experimental Design and Surface Modification.克服纳米颗粒临床转化中的障碍:实验设计和表面修饰的影响。
Int J Mol Sci. 2019 Nov 30;20(23):6056. doi: 10.3390/ijms20236056.